about
Novel mitochondrial targets for neuroprotectionThe effect of prenatal hypoxia on brain development: short- and long-term consequences demonstrated in rodent modelsVascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.Protection by low-dose kanamycin against noise-induced hearing loss in mice: dependence on dosing regimen and genetic backgroundProtection against noise-induced hearing loss in young CBA/J mice by low-dose kanamycinRecent findings and emerging questions in cochlear noise injury.The neuroprotective mechanism of brain ischemic preconditioning.HIF-1 alpha-deficient mice have increased brain injury after neonatal hypoxia-ischemia.Metal transcription factor-1 regulation via MREs in the transcribed regions of selenoprotein H and other metal-responsive genes.Regional genome transcriptional response of adult mouse brain to hypoxia.Hypoxic preconditioning protection is eliminated in HIF-1α knockout mice subjected to neonatal hypoxia-ischemia.Role of recurrent hypoxia-ischemia in preterm white matter injury severity.Signal transducers and activators of transcription: STATs-mediated mitochondrial neuroprotectionTissue oxygenation in brain, muscle, and fat in a rat model of sleep apnea: differential effect of obstructive apneas and intermittent hypoxia.Pre-conditioning induces the precocious differentiation of neonatal astrocytes to enhance their neuroprotective properties.Paradoxical exacerbation of neuronal injury in reperfused stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted miceThe HIF-1 inhibitor YC-1 decreases reactive astrocyte formation in a rodent ischemia modelMitochondrial Dihydrolipoamide Dehydrogenase is Upregulated in Response to Intermittent Hypoxic Preconditioning.Distal hypoxic stroke: a new mouse model of stroke with high throughput, low variability and a quantifiable functional deficitExpression of signal transduction genes differs after hypoxic or isoflurane preconditioning of rat hippocampal slice culturesRas family small GTPase-mediated neuroprotective signaling in stroke.Inhalational anesthetics as preconditioning agents in ischemic brain.Subfield-specific neurovascular remodeling in the entorhino-hippocampal-organotypic slice culture as a response to oxygen-glucose deprivation and excitotoxic cell death.Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons.HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model.Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.Inositol 1,4,5-triphosphate receptors and NAD(P)H mediate Ca2+ signaling required for hypoxic preconditioning of hippocampal neurons.Neuroprotection in the newborn infantProlyl 4 hydroxylase: a critical target in the pathophysiology of diseases.Preconditioning strategy in stem cell transplantation therapy.Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injuryEffect of oxygen concentrations on sodium iodide symporter expression and iodide uptake and hCG expression in human choriocarcinoma BeWo cells.RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.Comparison of in vivo and in vitro gene expression profiles in subventricular zone neural progenitor cells from the adult mouse after middle cerebral artery occlusionHypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart.Enhanced expression of the Flt-1 and Flk-1 receptor tyrosine kinases in a newborn piglet model of ischemic tolerance.Intermittent hypoxia protects cerebral mitochondrial function from calcium overload.Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function.Neonatal hypoxic ischaemic encephalopathy: current and future treatment options
P2860
Q27023108-DFB1F70D-791D-436D-82FB-90A7E332E0B9Q28245123-A8B0617F-59C7-4E3C-B6AA-5359881547D6Q28583917-FAAD5217-031C-4C02-BDFF-9A8998F95C3DQ30462907-416B1DE1-6FE2-4EA8-AD7E-76AEAA3CE98DQ30475308-FBC13B4B-8BBD-4A44-98A6-E1CDE7D6D9A1Q30485597-F1F1C60B-52EC-4079-9B86-48E923B403E8Q33552790-75C523AA-E891-4ACF-8BAF-1B4C3BC2466CQ33646635-930EAAD8-E904-4DCB-8C4F-FA442F36EDCFQ33679131-6C066AE9-52B7-4497-9C22-04051F8110EEQ34046347-12C5692A-CB4A-4926-A450-65D691F6D3D3Q34202384-1B981D3E-6482-4523-8689-8A07079E26E5Q34497855-1E8B262D-0F1D-4B17-9798-617D1DD6A439Q34805921-BDAB63D4-B0C1-40CE-8749-481F62C89632Q35110586-25A51DB0-2D71-4F24-BB6D-B4EB664E8CC8Q35157711-81AB5244-B24B-4E6E-A9C1-FB97E8B4A7EAQ35551581-7549E44D-E84D-4E5C-A38F-E70A5652E30FQ35682603-9B400554-A9E7-4DDF-AA26-D380CA71EF91Q35739510-B0CAF48A-701F-44E2-A36E-DF855518EE4EQ35947213-CD4437AE-DCDA-4174-86BA-5793C05AE59AQ36338260-010D0075-DD6B-4044-AE2A-1549816CD270Q36403779-1A21529A-AA3B-46BC-84F5-1731D48FDB4DQ36478937-1DE2B2A5-C891-4970-98F1-BC9B9BB43BB8Q36745064-BD1BADF4-93F8-470A-87C8-E28DC0D88FD8Q36841461-EE10AD5B-B043-4F23-80BA-C2F1A0E56A66Q37090306-77F53FC6-E685-49C8-9C5C-C89604ADD07DQ37158226-4E574669-B53B-48F3-A096-C3A3FA421372Q37198131-8ADFCCF9-0429-49D0-8BCB-1824F399FE43Q37452432-F80C329E-EF87-45B2-A4E5-3B3C8D3AA442Q38102681-CAFDA823-FDBD-43AD-8326-0357BC9998C6Q38126494-1B416439-0F81-43B6-B5DC-CAD4C6C9DBBAQ38571725-B2C37DED-9651-48DC-AF57-996908538D86Q39575674-13741D34-29D4-4E79-850C-0DF0A6C87F72Q40179965-B9527487-618B-464B-A558-98C28FC0C628Q42403952-97AFA873-ADF2-4E1E-8559-59C93542C8B6Q42424973-889E4850-DC2D-46CE-904C-BC87B3B70E52Q48134076-BB644434-3D19-4391-BE63-31FA9C15769BQ48272397-4A62D264-88BB-4CED-B8DC-AED1611E927DQ48935057-751D1583-76A0-4E0C-9262-9CA2F817E646Q54979172-D411A1E9-4192-41D3-BC86-26C15C1E6F51Q57405344-1102CC15-98FA-4618-A2F4-430AF27B7C76
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hypoxia preconditioning in the brain.
@ast
Hypoxia preconditioning in the brain.
@en
type
label
Hypoxia preconditioning in the brain.
@ast
Hypoxia preconditioning in the brain.
@en
prefLabel
Hypoxia preconditioning in the brain.
@ast
Hypoxia preconditioning in the brain.
@en
P2093
P2860
P356
P1476
Hypoxia preconditioning in the brain.
@en
P2093
Frank R Sharp
Huichun Xu
Ruiqiong Ran
P2860
P356
10.1159/000085979
P577
2005-03-01T00:00:00Z